Help us: Donate
Follow us on:
×

Tag: Ending Age-Related Diseases 2021

EARD2021 Daniel Belsky
At Ending Age-Related Diseases 2021, Daniel Belsky discussed the DunedinPACE and DunedinPoAm biomarkers and how biomarkers that measure the pace of aging might prove useful in the development of geroprotectors. Script Thanks everyone for sticking it out for this talk. I'm very pleased to join you and be able to share some of the work...
EARD2021 Daniel Ives
At Ending Age-Related Diseases 2021, Daniel Ives of Shift Bioscience discussed how genes themselves, rather than methylation, might provide effective clocks and therapeutic targets. Script The title of my talk is Targeting Safe Cellular Rejuvenation. There's a very powerful cellular rejuvenation paradigm that's been touched upon earlier, but it has a neoplastic risk, or cancer...
EARD2021 Greg Grinberg
At Ending Age-Related Diseases 2021, Greg Grinberg of ActualFood discussed philanthropy, what attracts people to causes like ours, and how we need to approach this subject. Script "It's ironic, isn't it? All this magnificent technology, we still find ourselves susceptible to the ravages of old age. Loss of dignity, slow betrayal of our bodies by...
EARD2021 Greg Fahy
At Ending Age-Related Diseases 2021, Greg Fahy discussed TRIIM-X, the ongoing continuation of his original TRIIM trial, along with some surprising findings from it. Script I'm just going to try to update everybody on the TRIIM-X clinical trial. I will explain where that came from, just to make sure everybody has the same background in...
EARD2021 Irina Conboy
At Ending Age-Related Diseases 2021, Irina Conboy discussed the effects of plasma dilution and heterochronic plasma exchange and their relationship to epigenetic alterations. Script Thank you for inviting me again, it's much appreciated. This is an excellent conference series. I will start by telling you that it is my deep belief that the path to...
EARD2021 Joao Pedro de Magalhaes
In his talk at Ending Age-Related Diseases 2021, João Pedro de Magalhães discussed the difference between longevity and rejuvenation along with the need for more ambitious research. Script I think it's a very exciting time to be working on longevity. I prepared a slightly different presentation like I did two years ago when I was...

Want the latest longevity news? Subscribe to our Newsletter!